Stimit builds an IP portfolio, a network of Key Opinion Leaders behind our endeavor, and we develop product solutions according to ISO 13485.
We progress and grow all the time, please contact us for more information.
Stimit AG plans to enter the market soon with a first product solution. This rapid time-to-market will be enabled by industrial partnerships and by using a lean, targeted product approach.
Stimit will create a continuous flow of product innovations backed by solid clinical data. Our product platform will address various disease states and applications which benefit from diaphragm activation.